Zai Lab Limited (ZLAB)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 15.74 |
| Open | 15.83 |
| Bid | 15.68 x 200 |
| Ask | 16.14 x 200 |
| Day's range | 15.83 - 15.93 |
| 52-week range | 13.48 - 39.50 |
| Volume | |
| Avg. volume | 644,400 |
| Market cap | 1.621B |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Shareholders in Zai Lab (NASDAQ:ZLAB) are in the red if they invested three years ago
As an investor, mistakes are inevitable. But really bad investments should be rare. So take a moment to sympathize with...
- GuruFocus.com
Chief Legal Officer Edmondson Frazor Titus III Sells 10,000 Shares of Zai Lab Ltd (ZLAB)
Zai Lab Ltd (NASDAQ:ZLAB), a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for cancer, autoimmune, and infectious diseases, has reported an insider sale according to a recent SEC filing.
- Insider Monkey
Zai Lab Limited (NASDAQ:ZLAB) Q4 2023 Earnings Call Transcript
Zai Lab Limited (NASDAQ:ZLAB) Q4 2023 Earnings Call Transcript February 28, 2024 Zai Lab Limited isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab Full Year 2023 […]
© 2024 Yahoo. All rights reserved.